key: cord-0920048-gk7cgpia
authors: Rossato, Luana; Negrão, Fabio Julio; Simionatto, Simone
title: Could the COVID-19 pandemic aggravate antimicrobial resistance?
date: 2020-06-27
journal: Am J Infect Control
DOI: 10.1016/j.ajic.2020.06.192
sha: a2f8a57d3f59be0de5f12e45a00fa102506159e1
doc_id: 920048
cord_uid: gk7cgpia

nan

and immunoinflammatory response (cytokine storm) [1] ; 2) Secondary infections were found in 50% of COVID-19 mortalities. Therefore, bacterial and/or fungal secondary infections or coinfections are a probable factors that affect mortality of critically ill patients with COVID-19 [1] ; 3) In hospital care the rate of antibiotics usage (94%-100%) was much higher than the reported incidence of secondary infection (10%-15%) [2] ; 4) During the COVID-19 pandemic hospitals are overcrowded, with some medical centers reporting 50% more patients than normal [2] . 

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study, The Lancet

Multi-hospital point prevalence study of healthcare-associated infections in 28 adult intensive care units in Brazil

Antibiotic Prescribing During Pediatric Direct-to-Consumer Telemedicine Visits

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study